Reexamination of the assessment criteria for rheumatoid arthritis disease activity based on comparison of the Disease Activity Score 28 with other simpler assessment methods

Modern Rheumatology

Volumn 23, Issue 2, 2013, Pages 260-268

  Fujiwara, Michio ^a   Kita, Yasuhiko ^a  

^a YOKOHAMA ROSAI HOSPITAL   (Japan)

Author keywords

CDAI; DAS28; Remission; Rheumatoid arthritis; SDAI

Indexed keywords

ANTIRHEUMATIC AGENT;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; DISABILITY; FEMALE; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; PHYSICAL EXAMINATION; REMISSION; RHEUMATOID ARTHRITIS; SEVERITY OF ILLNESS INDEX;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DISABILITY EVALUATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PHYSICAL EXAMINATION; REMISSION INDUCTION; SEVERITY OF ILLNESS INDEX;

EID: 84883140307     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-012-0652-7     Document Type: Article

References (23)

1. Prevoo ML, van't Hof MA, van Riel PL, Theunisse LA, Lubberts EW, van leeuwen MA, et al. Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis. 1990;49: 916-20.
2. Smolen JS, Breedveld FC, Schiff MH, Kalden JR, Emery P, Eberl G, et al. A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology (Oxford). 2003;42: 244-57.
3. Aletaha D, Nell VP, Stamm T, Uffmann M, Pflugbeil S, MAchold K, et al. Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score. Arthritis Res Ther. 2005;7:R796-806.
4. Pincus T, Bergman M, Yazici Y, et al. RAPID3 (routine assessment of patient index data 3), a rheumatoid arthritis index without formal joint counts for routine care: Proposed severity categories compared to disease activity score and clinical disease activity index categories. J Rheumatol. 2008;35: 2136-46.
5. Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Goldsmith C, et al. American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum. 1995;38: 727-35.
6. Aletaha D, Smolen JS. The simple disease activity index (SDAI) and the clinical disease activity index (CDAI). A review of their usefulness and validity in rheumatoid arthritis. Clin Exp Rheumatol. 2005;23[Suppl 39]:S100-8.
7. Funabashi K, Koyano S, Miura T, Hagiwara T, Okuda K, Matsubara T. Efficacy of tocilizumab and evaluation of clinical remission as determined CDAI and MMP-3 level. Mod Rheumatol. 2009;19: 507-12.
8. Pinals RS, Masi AT, Lansen RA. Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum. 1981;24: 1308-15.
9. Fransen J, van Riel PL. DAS remission cut points. Clin Exp Rheumatol. 2006;24[6 Suppl 43]:S-29-32.
10. Brown AK, Conaghan PG, Karim Z, Quinn MA, Ikeda K, Peterfy CG, et al. An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis. Arthritis Rheum. 2008;58(10): 2958-67.
11. Suzuki T, Ito S, Handa S, Kose K, Okamoto Y, Minami M, Hayashi T, Goto D, Matsumoto I, Sumida T. A new low-field extremity magnetic resonance imaging and proposed compact MRI score: evaluation of anti-tumor necrosis factor biologics on rheumatoid arthritis. Mod Rheumatol. 2009;19: 358-65.
12. Sokka T, et al. Remission and rheumatoid arthritis: data on patients receiving usual care in twenty-four countries. Arthritis Rheum. 2008;58: 2642-51.
13. Felson DT, Smolen JS, et al. American College of Rheumatology/ European League against rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Ann Rheum Dis. 2011;70: 404-13.
14. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31: 315-24.
15. Steinbrocker O, Traeger CH, Batterman RC. Therapeutic criteria in rheumatoid arthritis. JAMA. 1949;140: 659-62.
16. Hochberg MC, Chang RW, Dwosh I, et al. The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis. Arthritis Rheum. 1992;35: 498-502.
17. Pincus T, Summey JA, Soraci SA Jr, et al. Assessment of patient satisfaction in activities of daily living using a modified Stanford health assessment questionnaire. Arthritis Rheum. 1983;26: 1346-56.
18. Inoue E, Yamanaka H, Hara M, Tomatsu T, Kamatani N. Comparison of disease activity score (DAS)28-erythrocyte sedimentation rate and DAS28-C-reactive protein threshold values. Ann Rheum Dis. 2007;66: 407-9.
19. Passing H, Bablok W. A new biometrical procedure for testing the equality of measurements from two different analytical methods. J Clin Chem Clin Biochem. 1983;21: 709-20.
20. Radovits BJ, Fransen J, van Riel PL, et al. Influence of age and gender on the 28-joint Disease Activity Score (DAS-28) in rheumatoid arthritis. Ann Rheum Dis. 2008;67: 1127-37.
21. Costenbader KH, Chibnik LB, Schur PH. Discordance between erythrocyte sedimentation rate and C-reactive protein measurements: clinical signature. Clin Exp Rheumatol. 2007;25: 746-9.
22. Rosa Neto NS, de Carvalho JF, Shoenfeld Y. Screening tests for inflammatory activity: applications in rheumatology. Mod Rheumatol. 2009;19: 469-77.
23. Brocq O, Millasseau E, Albert C, et al. Effect of discontinuing TNFa antagonist therapy in patients with remission of rheumatoid arthritis. Joint Bone Spine. 2009;76: 350-5.